FDA Urges Court To Keep Abortion Drug Regulations Intact

By Emily Field · March 20, 2023, 6:37 PM EDT

The U.S. Food and Drug Administration told a Washington federal court that Democratic state attorneys general waited for more than two decades to challenge restrictions on abortion medication mifepristone, which in...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Response

Case Information

Case Title

State of Washington et al v. United States Food and Drug Administration et al

Case Number

1:23-cv-03026

Court

Washington Eastern

Nature of Suit

Other Statutes: Administrative Procedures Act/Review or Appeal of Agency Decision

Date Filed

February 23, 2023

Recent Articles By Emily

November 05, 2024
Target Inks Individual Deals Over 'Non-Drowsy' Flu Medicine
October 10, 2024
Animal Medication Co. Sued Over Dog Arthritis Treatment Risks
August 26, 2024
Rival Can't Avoid Drugmaker's False Ad Claim Over Pain Med
August 21, 2024
Spine Implant Caused Patient's TB, Suit Says
July 23, 2024
Meet The Lead Ozempic Lawyers
June 24, 2024
Ark. AG Sues Pharmacy Benefit Managers Over Opioids
May 03, 2024
6 States Strike $270M Opioid Deal With Amneal
April 17, 2024
FDA's Foot-Dragging On Menthol Ban Sparks Frustration
March 26, 2024
Opioid Public Nuisance Claims 'Unique,' Ohio High Court Told
March 25, 2024
What To Watch As Opioid Litigation Goes To Ohio High Court